MSTN and type 2 diabetes mellitus: Weight-bearing running has been shown to downregulate MSTN, thereby promoting the expression of Wnt and β-catenin in the femur of diabetic rats, reducing GSK-3β expression and enhancing T2DM bone metabolism [109].